FIELD: pharmaceutical chemistry.
SUBSTANCE: group of inventions relates to a compound of formula (1') and specific compounds indicated in the claims, their pharmacologically acceptable salts, a pharmaceutical composition, an application and a method for preventing and treating an inflammatory disease based on them. In the formula (1'), R1 represents a hydrogen atom, a carboxy group, a cyano group, a fluorine atom, a chlorine atom, a methyl group, an isopropyl group, a tert-butyl group, a trifluoromethyl group, a trifluoromethoxy group, a cyclopropylmethoxy group, 1,1-difluoro-2-methylpropyl group, 1,1-difluoro-2,2-dimethylpropyl group, 1-methyl-1-cyclobutyl group, methoxycarbonyl group, ethoxycarbonyl group, isopropoxycarbonyl group, 1-hydroxy-1-methylethyl group, azetidine-1-carbonyl group, 3-methyloxetan-3-yl group, 4,5-dihydrooxazol-2-yl group or cyclopropylcarbonyl group; R6d represents a hydrogen atom or a methyl group; A1 is ═N- or ═CH-; X is benzene, pyridine or cyclohexane, each containing 2 bonds; J is a ring selected from those given in the claims; Y and its substituents are presented in the claims.
EFFECT: 1,2,4-triazole derivatives that increase the content of IL-10 which can be used to prevent and treat inflammatory diseases.
22 cl, 7 dwg, 33 tbl, 40 ex
Title | Year | Author | Number |
---|---|---|---|
THIOPHENE DERIVATIVE AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1997 |
|
RU2172737C2 |
DERIVATIVES OF AZOLE, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION | 1993 |
|
RU2116304C1 |
HYBRID DERIVATIVES OF (1H-1,2,4) TRIAZOLE AND SULPHUR-CONTAINING HETEROCYCLES: DERIVATIVES OF THIAZOLIDINE-2,4-DIONE, THIOMORPHOLINE-3-ONE, AND 1,4-THIAZEPAN-3-ONE, EXHIBITING ANTIMICROBIAL ACTIVITY | 2020 |
|
RU2771027C1 |
PRODRUG OF TRIAZOLONE COMPOUND | 2011 |
|
RU2581369C2 |
NEW TRIAZOLOPYRASINE DERIVATIVES AND THEIR APPLICATION | 2013 |
|
RU2643361C2 |
SUBSTITUTED [1,2,4]TRIAZOLO[4,3-a]PYRIDINES, DEMONSTRATING PROPERTIES OF ANTAGONISTS OF ADENOSINE A2A RECEPTORS, AND THEIR APPLICATION | 2013 |
|
RU2534804C1 |
BI-ARYL-META-PYRIMIDINE KINASE INHIBITORS | 2006 |
|
RU2597364C2 |
BI-ARYL-META-PYRIMIDINE KINASE INHIBITORS | 2006 |
|
RU2589878C2 |
ARYLSULFONYLMETHYL OR ARYLSULFONAMIDE DERIVATIVES OF AROMATICS, PHARMACEUTICAL COMPOSITION BASED ON THEM AND WAY OF TREATMENT AGAINST ABNORMALITIES RESPONSIVE TO DOPAMINE D RECEPTOR LIGAND TREATMENT, WITH THEIR HELP | 2005 |
|
RU2442781C2 |
CYCLIC CYANOENONE DERIVATIVES AS KEAP1 MODULATORS | 2021 |
|
RU2822828C1 |
Authors
Dates
2023-04-28—Published
2018-09-13—Filed